Gene therapy and molecular approaches to the treatment of hereditary muscular disorders

被引:5
作者
Fletcher, S
Wilton, SD
Howell, JM
机构
[1] Murdoch Univ, Div Vet & Biomed Sci, Murdoch, WA 6150, Australia
[2] Univ Western Australia, Australian Neuromuscular Res Inst, Perth, WA, Australia
[3] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA, Australia
关键词
D O I
10.1097/00019052-200010000-00008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Gene therapy for inherited muscle disease is an active area of research and development. Initial emphasis has been on gene replacement but alternative approaches are increasingly being considered in order to overcome difficulties, such as the immune rejection of transduced cells, the need for appropriate and tissue-specific control of expression, and the requirement for systemic spread in some conditions. However, the most significant obstacles to the clinical success of gene therapy are still the lack of efficiency and accuracy of gene medicine delivery. Curr Opin Neurol 13:553-560. (C) 2000 Lippincott Williams & Wilkins.
引用
收藏
页码:553 / 560
页数:8
相关论文
共 98 条
  • [1] Importance of nucleotide sequence and chemical modifications of antisense oligonucleotides
    Agrawal, S
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1489 (01): : 53 - 68
  • [2] Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-α-glucosidase
    Amalfitano, A
    McVie-Wylie, AJ
    Hu, H
    Dawson, TL
    Raben, N
    Plotz, P
    Chen, YT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (16) : 8861 - 8866
  • [3] A method for the preparation of highly purified adeno-associated virus using affinity column chromatography, protease digestion and solvent extraction
    Anderson, R
    Macdonald, I
    Corbett, T
    Whiteway, A
    Prentice, HG
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2000, 85 (1-2) : 23 - 34
  • [4] Systemic effect of human growth hormone after intramuscular injection of a single dose of a muscle-specific gene medicine
    Anwer, K
    Shi, M
    French, MF
    Muller, SR
    Chen, W
    Liu, QS
    Proctor, BL
    Wang, JJ
    Mumper, RJ
    Singhal, A
    Rolland, AP
    Alila, HW
    [J]. HUMAN GENE THERAPY, 1998, 9 (05) : 659 - 670
  • [5] Reversal of metabolic block in glycolysis by enzyme replacement in triosephosphate isomerase-deficient cells
    Ationu, A
    Humphries, A
    Lalloz, MRA
    Arya, R
    Wild, B
    Warrilow, J
    Morgan, J
    Bellingham, AJ
    Layton, DM
    [J]. BLOOD, 1999, 94 (09) : 3193 - 3198
  • [6] Local and distant transfection of mdx muscle fibers with dystrophin and LacZ genes delivered in vivo by synthetic microspheres
    Baranov, A
    Glazkov, P
    Kiselev, A
    Ostapenko, O
    Mikhailov, V
    Ivaschenko, T
    Sabetsky, V
    Baranov, V
    [J]. GENE THERAPY, 1999, 6 (08) : 1406 - 1414
  • [7] Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection
    Barry, ME
    Pinto-González, D
    Orson, FM
    McKenzie, GJ
    Petry, GR
    Barry, MA
    [J]. HUMAN GENE THERAPY, 1999, 10 (15) : 2461 - 2480
  • [8] Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice
    Barton-Davis, ER
    Cordier, L
    Shoturma, DI
    Leland, SE
    Sweeney, HL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (04) : 375 - 381
  • [9] Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source
    Beauchamp, JR
    Morgan, JE
    Pagel, CN
    Partridge, TA
    [J]. JOURNAL OF CELL BIOLOGY, 1999, 144 (06) : 1113 - 1121
  • [10] Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line
    Bedwell, DM
    Kaenjak, A
    Benos, DJ
    Bebok, Z
    Bubien, JK
    Hong, J
    Tousson, A
    Clancy, JP
    Sorscher, EJ
    [J]. NATURE MEDICINE, 1997, 3 (11) : 1280 - 1284